Bronchiectasis Clinical Trials

83 recruiting

Bronchiectasis Trials at a Glance

76 actively recruiting trials for bronchiectasis are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in London, Wuhan, and Shanghai. Lead sponsors running bronchiectasis studies include Shanghai Pulmonary Hospital, Shanghai, China, Mayo Clinic, and Assiut University.

Browse bronchiectasis trials by phase

Treatments under study

About Bronchiectasis Clinical Trials

Looking for clinical trials for Bronchiectasis? There are currently 83 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchiectasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchiectasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 76 trials

Recruiting
Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim1,755 enrolled494 locationsNCT06872892
Recruiting

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

PneumothoraxCOPDPneumonia+4 more
Assiut University700 enrolled1 locationNCT06983366
Recruiting

HFNC in Management of Bronchiectasis Exacerbation

Bronchiectasis
Assiut University20 enrolled1 locationNCT05741697
Recruiting

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

Non-cystic Fibrosis Bronchiectasis
AstraZeneca320 enrolled38 locationsNCT07245407
Recruiting
Not Applicable

Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Physio-Assist622 enrolled57 locationsNCT06487273
Recruiting

Natural History of Bronchiectasis

Cystic FibrosisBronchiectasisAutoimmune Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI)900 enrolled1 locationNCT00943514
Recruiting
Phase 1Phase 2

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis
Genentech, Inc.128 enrolled7 locationsNCT06603246
Recruiting
Not Applicable

OLE Therapy With BE Patients in Home Care Study

BronchiectasisPulmonary Exacerbation
Delve Health85 enrolled5 locationsNCT06926881
Recruiting

Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)

Bronchiectasis Adult
Synchrony-Medical, Ltd200 enrolled3 locationsNCT07135284
Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Bronchiectasis With Pseudomonas Aeruginosa Colonization
AstraZeneca435 enrolled182 locationsNCT07088926
Recruiting

Determination of Physical Fitness Level in Bronchiectasis

Pediatric Patients With Bronchiectasis
Melis Usul50 enrolled2 locationsNCT07121218
Recruiting

Correlation of Inflammatory Markers and Radiological Findings in Stable Bronchiectasis Patients With Exacerbation Phenotype

Correlation of Inflammatory Markers and Radiological Findings in Stable Bronchiectasis Patients
Sohag University100 enrolled1 locationNCT07495982
Recruiting
Phase 1Phase 2

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

Bronchiectasis
Chiesi Farmaceutici S.p.A.45 enrolled9 locationsNCT06166056
Recruiting
Not Applicable

Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis

Bronchiectasis Adult
IRCCS Azienda Ospedaliero-Universitaria di Bologna40 enrolled1 locationNCT06801327
Recruiting

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

BronchiectasisNontuberculous Mycobacteria
NYU Langone Health1,000 enrolled1 locationNCT02779478
Recruiting

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

AsthmaChronic Obstructive Pulmonary DiseaseCystic Fibrosis+2 more
CHU de Reims470 enrolled1 locationNCT07274631
Recruiting

Implementation of digitally-supported self-management and pulmonary rehabilitation in people with chronic respiratory disease

AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+1 more
Northern Sydney Local Health District138 enrolled3 locationsACTRN12626000197336
Recruiting
Phase 4

Itraconazole Therapy In Bronchiectasis With Airway Mold

BronchiectasisFungal Infection of Upper Respiratory Tract
Mayo Clinic30 enrolled1 locationNCT07283497
Recruiting
Not Applicable

Functional Inspiratory Training in Bronchiectasis

BronchiectasisFunctional Inspiratory Muscle Training
Elif Kabasakal38 enrolled1 locationNCT07188675
Recruiting
Not Applicable

Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients

Post-Lung Transplantation Bronchiectasis
Mayo Clinic90 enrolled1 locationNCT04582279